Physical Activity and the Pandemic Survey
Has your activity changed since the start of the pandemic?
Has your activity changed since the start of the pandemic?
The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.
UK experts are set to run a multi-arm, multi-stage trial which will test a range of drugs already approved for other illnesses for the treatment of multiple sclerosis (MS). The ‘Octopus trial’ will allow three drugs to be tested at the same time.
All-Ireland MS Research Network (AIMS-RN) provides hope to those affected by multiple sclerosis
Lauren McCauley, person living with MS, patient advisor and a participant
Conducting research remotely by Fionnuala Rogers, Research Assistant at NUI Galway with the COB-MS feasibility trial.
A case study of anxiety in MS by Dr Rebecca Maguire - Associate Professor, Department of Psychology, Maynooth University
Researchers at Trinity College Dublin and Beaumont Hospital are carrying out a study exploring cognitive changes (thinking and memory) in Multiple Sclerosis.
© 2010 - 2024 Multiple Sclerosis Society of Ireland